# Open Label Treatment of Severe Tactile Defensiveness With Intrathecal Baclofen

> **NCT01352611** · NA · WITHDRAWN · sponsor: **University of Missouri-Columbia**

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **DRUG:** baclofen, intrathecal

## Key facts

- **NCT ID:** NCT01352611
- **Lead sponsor:** University of Missouri-Columbia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-09
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No subjects enrolled.
- **Last updated:** 2016-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01352611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01352611, "Open Label Treatment of Severe Tactile Defensiveness With Intrathecal Baclofen". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT01352611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*